Zoetis Inc., the world's leading animal health company, announced updates on its scientific research and development during an Innovation Webcast. The company highlighted its robust and diversified R&D pipeline, which targets significant unmet medical needs in animal health. Zoetis is expanding into new therapeutic areas, including chronic kidney disease, oncology, and cardiology, representing over $5 billion in total addressable market opportunity. The webcast emphasized Zoetis' integrated science-to-scale model, leveraging scientific and veterinary expertise to efficiently transform discoveries into approved products. These updates were presented during the webcast and underscore Zoetis' commitment to driving innovation and long-term growth in animal health.